INSPIREMD INC NSPR
COM · Common Stock · CUSIP 45779A846
- SectorHealth care
- IndustrySurgical & Medical Instruments & Apparatus
- HeadquartersMiami, FL
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.78. Options: 0 managers hold calls (— notional), 1 hold puts ($17.8k).
Trends to Q4 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 16 |
| Q4 2022 | 16 |
| Q1 2023 | 15 |
| Q2 2023 | 23 |
| Q3 2023 | 26 |
| Q4 2023 | 29 |
| Q1 2024 | 28 |
| Q2 2024 | 25 |
| Q3 2024 | 29 |
| Q4 2024 | 31 |
| Q1 2025 | 36 |
| Q2 2025 | 37 |
| Q3 2025 | 41 |
| Q4 2025 | 45 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2024 | 5 | 7 |
| Q2 2024 | 4 | 7 |
| Q3 2024 | 7 | 6 |
| Q4 2024 | 9 | 5 |
| Q1 2025 | 11 | 6 |
| Q2 2025 | 17 | 8 |
| Q3 2025 | 25 | 8 |
| Q4 2025 | 19 | 14 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q1 2025 | $0 | $9.4k | — |
| Q2 2025 | $0 | $7.9k | — |
| Q3 2025 | $0 | $24.3k | — |
| Q4 2025 | $0 | $17.8k | — |
Biggest buyers
| ORBIMED ADVISORS LLC | Added | +1.0m |
| Aberdeen Group plc | Added | +692.2k |
| INGALLS & SNYDER LLC | Added | +159.3k |
| CITADEL ADVISORS LLC | Added | +155.8k |
| ESSEX INVESTMENT MANAGEMENT CO LLC | New | +114.1k |
| Legato Capital Management LLC | New | +26.9k |
| Virtu Financial LLC | New | +17.7k |
| XTX Topco Ltd | New | +17.0k |
| GOLDMAN SACHS GROUP INC | New | +12.9k |
| TWO SIGMA SECURITIES, LLC | New | +11.8k |
Biggest sellers
| Ghisallo Capital Management LLC | Sold out | -921.6k |
| Soleus Capital Management, L.P. | Reduced | -320.9k |
| Huntleigh Advisors, Inc. | Sold out | -264.0k |
| Schonfeld Strategic Advisors LLC | Reduced | -62.8k |
| IRONWOOD INVESTMENT MANAGEMENT LLC | Sold out | -61.6k |
| MORGAN STANLEY | Reduced | -44.2k |
| Mesirow Financial Investment Management, Inc. | Sold out | -30.0k |
| Parkman Healthcare Partners LLC | Reduced | -24.1k |
| MILLENNIUM MANAGEMENT LLC | Reduced | -23.3k |
| Uniting Wealth Partners, LLC | Sold out | -21.1k |
Biggest calls
| None |
Biggest puts
| GROUP ONE TRADING LLC | Reduced | $17.8k10.0k shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Nantahala Capital Management, LLC 13G · institution no change · filed 2026-05-15 | 10.0% |
| MARSHALL WACE, LLP 13G · institution filed 2025-11-14 | 10.0% |
| Rosalind Advisors, Inc. 13G · exempt (held before listing) -0.7 pts · filed 2026-02-11 | 9.2% |
Lawless Michael A
13D · may seek influence
new · filed 2025-10-29
Stated purposeItem 3 above is hereby incorporated into this Item 4 by reference. The Reporting Person serves as an executive officer of the Issuer and, in such capacity, may be involved in reviewing transactions involving the Issuer and may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. As of the date hereof, the Reporting Person in his individual capacity does not have any present plans or proposals that relate to, or would result in, any actions or events specified in clauses (a) through (j) of Item 4 to Schedule 13D. The Reporting Person may, at any time and from time to time, (i) review or reconsider his position in the Issuer or change his purpose or formulate plans or … Full filing |
8.6% |
| Aberdeen Group plc 13G · institution +1.5 pts · filed 2026-02-02 | 7.5% |
| ORBIMED ADVISORS LLC 13G · passive investor +3.3 pts · filed 2026-02-17 | 7.4% |
| Parkman Healthcare Partners LLC 13G · institution new · filed 2025-11-14 | 5.8% |
| Nantahala Capital Partners Limited Partnership 13G · passive investor filed 2025-11-14 | 5.7% |
Slosman Marvin
13D · may seek influence
new · filed 2026-04-24
Stated purposeItem 3 above is hereby incorporated into this Item 4 by reference. The Reporting Person serves as an executive officer of the Issuer and, in such capacity, may be involved in reviewing transactions involving the Issuer and may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. As of the date hereof, the Reporting Person in his individual capacity does not have any present plans or proposals that relate to, or would result in, any actions or events specified in clauses (a) through (j) of Item 4 to Schedule 13D. The Reporting Person may, at any time and from time to time, (i) review or reconsider his position in the Issuer or change his purpose or formulate plans or … Full filing |
5.2% |
Fell to 5% or below in the last year: Velan Capital Investment Management LP (5.0%, 2026-05-15)
Insider purchases and sales in Q4 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 0 | — | 0 | — | — |
| Q4 2024 | 0 | — | 0 | — | — |
| Q1 2025 | 0 | — | 1 | $124.3k | — |
| Q2 2025 | 0 | — | 1 | $37.6k | — |
| Q3 2025 | 4 | $250.0k | 0 | — | — |
| Q4 2025 | 1 | $54.8k | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-12-09 | Stuka Paul Director | Bought | $4.9k2.7k shares |
| 2025-12-05 | Stuka Paul Director | Bought | $9.4k5.1k shares |
| 2025-12-04 | Stuka Paul Director | Bought | $18.7k10.1k shares |
| 2025-11-12 | Stuka Paul Director | Bought | $21.8k13.4k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q4 2025
| Manager | Shares | Change |
|---|---|---|
| Rosalind Advisors, Inc. 2.53% of their portfolio | 3.9m $7.0m | Unchanged |
| Nantahala Capital Management, LLC 0.36% of their portfolio | 3.4m $6.0m | Unchanged |
| Aberdeen Group plc 0.01% of their portfolio | 3.2m $5.6m | Added +692.2k |
| ORBIMED ADVISORS LLC 0.11% of their portfolio | 3.1m $5.6m | Added +1.0m |
| Parkman Healthcare Partners LLC 0.41% of their portfolio | 2.4m $4.3m | Reduced -24.1k |
| Velan Capital Investment Management LP 2.22% of their portfolio | 2.1m $3.8m | Unchanged |
| MARSHALL WACE, LLP 0.00% of their portfolio | 1.9m $3.3m | Unchanged |
| Soleus Capital Management, L.P. 0.09% of their portfolio | 1.1m $2.0m | Reduced -320.9k |
| PURA VIDA INVESTMENTS, LLC 3.00% of their portfolio | 450.5k $801.9k | Unchanged |
| INGALLS & SNYDER LLC 0.03% of their portfolio | 384.3k $684.0k | Added +159.3k |
| Affiance Financial, LLC 0.07% of their portfolio | 250.4k $445.7k | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 193.7k $344.8k | Added +155.8k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 124.1k $220.9k | Reduced -23.3k |
| ESSEX INVESTMENT MANAGEMENT CO LLC 0.03% of their portfolio | 114.1k $203.1k | New |
| BlackRock, Inc. 0.00% of their portfolio | 60.9k $108.4k | Added +7.2k |
| COURIER CAPITAL LLC 0.01% of their portfolio | 55.0k $97.9k | Unchanged |
| VESTIA PERSONAL WEALTH ADVISORS 0.03% of their portfolio | 42.4k $68.7k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 41.8k $74.5k | Reduced -44.2k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 33.6k $59.8k | Unchanged |
| COMMONWEALTH EQUITY SERVICES, LLC 0.00% of their portfolio | 32.5k $57.9k | Unchanged |
| Legato Capital Management LLC 0.00% of their portfolio | 26.9k $47.8k | New |
| Schonfeld Strategic Advisors LLC 0.00% of their portfolio | 23.3k $41.5k | Reduced -62.8k |
| Creative Planning 0.00% of their portfolio | 19.7k $35.1k | Added +145 |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 18.2k $32.5k | Unchanged |
| Virtu Financial LLC 0.00% of their portfolio | 17.7k $31.0k | New |
| XTX Topco Ltd 0.00% of their portfolio | 17.0k $30.3k | New |
| Avestar Capital, LLC 0.00% of their portfolio | 15.0k $26.7k | Unchanged |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 12.9k $23.0k | New |
| TWO SIGMA SECURITIES, LLC 0.00% of their portfolio | 11.8k $21.0k | New |
| Pallas Capital Advisors LLC 0.00% of their portfolio | 11.0k $19.6k | Unchanged |
| HRT FINANCIAL LP 0.00% of their portfolio | 10.1k $17.0k | New |
| BROWN ADVISORY INC 0.00% of their portfolio | 10.0k $17.8k | Unchanged |
| McKinley Carter Wealth Services, Inc. 0.00% of their portfolio | 10.0k $17.8k | Unchanged |
| AdvisorNet Financial, Inc 0.00% of their portfolio | 8.8k $15.6k | Unchanged |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 5.5k $9.7k | New |
| GROUP ONE TRADING LLC 0.00% of their portfolio | 4.0k $7.1k | Unchanged |
| SIMPLEX TRADING, LLC 0.00% of their portfolio | 3.2k $5.7k | Added +2.7k |
| Farther Finance Advisors, LLC 0.00% of their portfolio | 1.0k $1.8k | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 180 $0 | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 113 $201 | Reduced -495 |
| UBS Group AG 0.00% of their portfolio | 32 $57 | New |
| JONES FINANCIAL COMPANIES LLLP 0.00% of their portfolio | 27 $48 | New |
| Global Retirement Partners, LLC 0.00% of their portfolio | 27 $48 | Unchanged |
| BELLEVUE ASSET MANAGEMENT, LLC 0.00% of their portfolio | 25 $2.3k | Unchanged |
| CITIGROUP INC 0.00% of their portfolio | 1 $2 | New |